SCHEMBL5050247

SCHEMBL5050247

CCCCCCSc1nc(C)cc(CN2CCC3(CC2)OCCO3)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.38
HTT P42858 3/20 0.38
GAA P10253 2/20 0.38
GPR84 Q9NQS5 1/20 0.36
HSD17B10 Q99714 1/20 0.35
MAPT P10636 3/20 0.33
THRB P10828 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HPGD P15428 3/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ATM Q13315 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ALDH1A1 P00352 3/20 0.31
KDM4E B2RXH2 1/20 0.31
TSHR P16473 1/20 0.31
LMNA P02545 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5042209 0.85 HSD17B10 (0.46) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5049081 0.84 HSD17B10 (0.47) SMN1; SMN2HTTGAAHSD17B10THRB
SCHEMBL5045769 0.84 SMN1; SMN2 (0.43) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5049973 0.83 SMN1; SMN2 (0.43) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5047348 0.83 SMN1; SMN2 (0.43) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5049995 0.83 SMN1; SMN2 (0.43) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5046236 0.82 HSD17B10 (0.46) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5042347 0.81 HSD17B10 (0.48) SMN1; SMN2HTTHSD17B10THRBCYP1A2
SCHEMBL5047449 0.79 SPHK1 (0.40) SMN1; SMN2HTTGAAGPR84HSD17B10
SCHEMBL5050013 0.78 SMN1; SMN2 (0.39) SMN1; SMN2HTTGAAGPR84MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351700-B2 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors HOFFMANN-LA ROCHE INC. (US) 2008-04-01 US claimed
EP-1725239-A1 4-(SULFANYL-PYRIMIDIN-4-YLMETHYL)-MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS GABA RECEPTOR LIGANDS FOR THE TREATMENT OF ANXIETY, DEPRESSION AND EPILEPSY F.HOFFMANN-LA ROCHE AG (CH) 2006-11-29 EP disclosed
WO-2005094828-A1 4- (SULFANYL-PYRIMIDIN-4-YLMETHYL) -MORPHOLINE DERIVATIVES AND RELATED COMPOUNDS AS GABA RECEPTOR LIGANDS FOR THE TREATMENT OF ANXIETY, DEPRESSION AND EPILEPSY F. HOFFMANN-LA ROCHE AG (CH) 2005-10-13 WO disclosed